New study aims to outsmart hepatitis b drug resistance
NCT ID NCT07459426
First seen Mar 12, 2026 · Last updated Apr 28, 2026 · Updated 2 times
Summary
This study looks at how the hepatitis B virus changes over time to resist treatment. Researchers will analyze blood samples from 700 adults with chronic hepatitis B in Turkey using advanced genetic sequencing. The goal is to better understand which patients are at risk for drug resistance, especially those who have taken older medications like lamivudine, and help doctors choose the most effective treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gaziantep University
Gaziantep, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.